Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.

Int J Nanomedicine · 2019 · PMC6689768 · PMID 31496685

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When comparing all treatment groups, the P1 NPs demonstrated significantly improved growth retardation compared to P2 NPs and nab-PTX, but did not reach statistical significance in comparison with free PTX at day 18 (when the P2 group had to be discontinued).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.